Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.3 USD | +3.12% | -10.60% | -8.51% |
May. 21 | Oppenheimer Adjusts Savara Price Target to $11 From $9.50, Maintains Outperform Rating | MT |
May. 09 | Savara Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.51% | 594M | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-2.50% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- SVRA Stock
- News Savara Inc.
- Savara : Doses First Patient in Late-Stage Trial of Molgramostim in Lung Disease